5 min listen
The Choice of Neoadjuvant Therapy for Hormone Receptor Positive Breast Cancer
FromSurgOnc Today®
ratings:
Length:
30 minutes
Released:
May 8, 2020
Format:
Podcast episode
Description
In this episode of SurgOnc Today™, Armando Giuliano, MD, Tari King, MD and Otto Metzger, MD, discuss the choice between preoperative endocrine therapy and preoperative chemotherapy in hormone receptor positive breast cancer patients. Evaluation and treatment is discussed for a post-menopausal woman presenting a 3.4 cm node negative, invasive ductal carcinoma
Released:
May 8, 2020
Format:
Podcast episode
Titles in the series (99)
SSO Clinical Investigator Award: Perspectives from Ronald DeMatteo, MD: In this episode, Sandra Wong, MD, speaks with Ronald DeMatteo, MD, about the opportunities that stemmed from receiving the 2008 SSO Clinical Investigator Award. Dr. DeMatteo shares his perspective on how the CIA award came at a critical time and... by SurgOnc Today®